A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
Condition(s):Advanced MalignancyLast Updated:April 9, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Advanced MalignancyLast Updated:April 9, 2010Completed
Condition(s):Infant, Premature, DiseasesLast Updated:October 12, 2018Completed
Condition(s):Age-related Macular DegenerationLast Updated:November 30, 2017Completed
Condition(s):Macular DegenerationLast Updated:October 1, 2014Completed
Condition(s):AMDLast Updated:July 20, 2018Completed
Condition(s):Ophthalmology, Macular DegenerationLast Updated:January 27, 2014Completed
Condition(s):Acute Ischemic StrokeLast Updated:August 11, 2020Completed
Condition(s):Age Related Macular DegenerationLast Updated:August 11, 2015Unknown status
Condition(s):Diabetic Retinopathy; Diabetic Macular EdemaLast Updated:June 18, 2023Completed
Condition(s):Adrenal Insufficiency; Osteopenia, Osteoporosis; Steroid Suppression of ACTH SecretionLast Updated:February 21, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.